Cargando…

Les effets épigénétiques du cannabis/tétrahydrocannabinol()

The almost pandemic spread of cannabis among adolescents and young adults, especially in France, justifies the attention given to the consequences, not only acute but also delayed, of this intoxication. In the latter case, epigenetic mechanisms occur. We will first recall various types of epigenetic...

Descripción completa

Detalles Bibliográficos
Autor principal: Costentin, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS on behalf of l'Académie nationale de médecine. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158823/
https://www.ncbi.nlm.nih.gov/pubmed/32296244
http://dx.doi.org/10.1016/j.banm.2020.04.004
_version_ 1783522563131965440
author Costentin, J.
author_facet Costentin, J.
author_sort Costentin, J.
collection PubMed
description The almost pandemic spread of cannabis among adolescents and young adults, especially in France, justifies the attention given to the consequences, not only acute but also delayed, of this intoxication. In the latter case, epigenetic mechanisms occur. We will first recall various types of epigenetic modifications involving either chromatin histones, mainly methylations or acetylations, either DNA, by methylation of cytosines. Such modifications caused by the tetrahydrocannabinol/THC of cannabis can intervene: either at the level of gametes before procreation, or at different points of the life cycle. These epigenetic modifications are associated with an increase in vulnerability to drug addiction, involving dopamine D(2) receptors in the nucleus accumbens, overexpression of enkephalin precursor synthesis, modifications of: CB(1) receptors of endocannabinoids, glutamic acid receptors, GABA receptors, proteins involved in synaptic plasticity… These changes can also affect: immune system, cognitive activities, development of psychiatric diseases, related to disturbances of brain maturation. The knowledge that accumulates in this respect is the opposite of the ambient trivialization of this drug. They impose sending an alert to the public authorities and to the public, especially young people, warning on the risks associated with this drug use and abuse.
format Online
Article
Text
id pubmed-7158823
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Masson SAS on behalf of l'Académie nationale de médecine.
record_format MEDLINE/PubMed
spelling pubmed-71588232020-04-15 Les effets épigénétiques du cannabis/tétrahydrocannabinol() Costentin, J. Bull Acad Natl Med Revue Générale The almost pandemic spread of cannabis among adolescents and young adults, especially in France, justifies the attention given to the consequences, not only acute but also delayed, of this intoxication. In the latter case, epigenetic mechanisms occur. We will first recall various types of epigenetic modifications involving either chromatin histones, mainly methylations or acetylations, either DNA, by methylation of cytosines. Such modifications caused by the tetrahydrocannabinol/THC of cannabis can intervene: either at the level of gametes before procreation, or at different points of the life cycle. These epigenetic modifications are associated with an increase in vulnerability to drug addiction, involving dopamine D(2) receptors in the nucleus accumbens, overexpression of enkephalin precursor synthesis, modifications of: CB(1) receptors of endocannabinoids, glutamic acid receptors, GABA receptors, proteins involved in synaptic plasticity… These changes can also affect: immune system, cognitive activities, development of psychiatric diseases, related to disturbances of brain maturation. The knowledge that accumulates in this respect is the opposite of the ambient trivialization of this drug. They impose sending an alert to the public authorities and to the public, especially young people, warning on the risks associated with this drug use and abuse. Published by Elsevier Masson SAS on behalf of l'Académie nationale de médecine. 2020-06 2020-04-15 /pmc/articles/PMC7158823/ /pubmed/32296244 http://dx.doi.org/10.1016/j.banm.2020.04.004 Text en © 2020 Published by Elsevier Masson SAS on behalf of l'Académie nationale de médecine. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Revue Générale
Costentin, J.
Les effets épigénétiques du cannabis/tétrahydrocannabinol()
title Les effets épigénétiques du cannabis/tétrahydrocannabinol()
title_full Les effets épigénétiques du cannabis/tétrahydrocannabinol()
title_fullStr Les effets épigénétiques du cannabis/tétrahydrocannabinol()
title_full_unstemmed Les effets épigénétiques du cannabis/tétrahydrocannabinol()
title_short Les effets épigénétiques du cannabis/tétrahydrocannabinol()
title_sort les effets épigénétiques du cannabis/tétrahydrocannabinol()
topic Revue Générale
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158823/
https://www.ncbi.nlm.nih.gov/pubmed/32296244
http://dx.doi.org/10.1016/j.banm.2020.04.004
work_keys_str_mv AT costentinj leseffetsepigenetiquesducannabistetrahydrocannabinol